{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:30:51Z","timestamp":1783474251524,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,12,15]],"date-time":"2011-12-15T00:00:00Z","timestamp":1323907200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s00535-011-0501-z","type":"journal-article","created":{"date-parts":[[2011,12,14]],"date-time":"2011-12-14T09:12:39Z","timestamp":1323853959000},"page":"387-393","source":"Crossref","is-referenced-by-count":21,"title":["Small bowel injury induced by selective cyclooxygenase-2 inhibitors: a prospective, double-blind, randomized clinical trial comparing celecoxib and meloxicam"],"prefix":"10.1007","volume":"47","author":[{"given":"Yuji","family":"Maehata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Esaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshibumi","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Kochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Shikata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,15]]},"reference":[{"key":"501_CR1","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(88)92892-9","volume":"2","author":"DY Graham","year":"1988","unstructured":"Graham DY, Agrawal NM, Roth SH. Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet. 1988;2:1277\u201380.","journal-title":"Lancet"},{"key":"501_CR2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/rheumatology\/25.1.50","volume":"25","author":"AJ Collins","year":"1986","unstructured":"Collins AJ, Davies J, Dixon SA. Contrasting presentation and findings between patients with rheumatic complaints taking nonsteroidal anti-inflammatory drugs and a general population referred for endoscopy. Br J Rheumatol. 1986;25:50\u20133.","journal-title":"Br J Rheumatol"},{"key":"501_CR3","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1056\/NEJM199209103271101","volume":"327","author":"MC Allison","year":"1992","unstructured":"Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med. 1992;327:749\u201354.","journal-title":"N Engl J Med"},{"key":"501_CR4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1572-0241.2001.03530.x","volume":"96","author":"K Kurahara","year":"2001","unstructured":"Kurahara K, Matsumoto T, Iida M, Honda K, Yao T, Fujishima M. Clinical and endoscopic features of nonsteroidal anti-inflammatory drug-induced colonic ulcerations. Am J Gastroenterol. 2001;96:473\u201380.","journal-title":"Am J Gastroenterol"},{"key":"501_CR5","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1572-0241.2004.30220.x","volume":"99","author":"Y Amano","year":"2004","unstructured":"Amano Y, Kushiyama Y, Takahashi Y, Ishihara S, Adachi K, Kinoshita Y. Prevalence of ileo-colonic ulcerative lesions in chronic NSAIDs users. Am J Gastroenterol. 2004;99:1193.","journal-title":"Am J Gastroenterol"},{"key":"501_CR6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1542-3565(04)00603-2","volume":"3","author":"DY Graham","year":"2005","unstructured":"Graham DY, Opekun AR, Willingham FF, Qureshi WA. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol. 2005;3:55\u20139.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"501_CR7","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1053\/j.gastro.2005.03.020","volume":"128","author":"L Maiden","year":"2005","unstructured":"Maiden L, Thjodleifsson B, Theodors A, Gonzalez J, Bjarnason I. A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology. 2005;128:1172\u20138.","journal-title":"Gastroenterology"},{"key":"501_CR8","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1080\/00365520701794121","volume":"43","author":"T Matsumoto","year":"2008","unstructured":"Matsumoto T, Kudo T, Esaki M, Yano T, Yamamoto H, Sakamoto C, et al. Prevalence of non-steroidal anti-inflammatory drug-induced enteropathy determined by double-balloon endoscopy: a Japanese multicenter study. Scand J Gastroenterol. 2008;43:490\u20136.","journal-title":"Scand J Gastroenterol"},{"key":"501_CR9","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","volume":"284","author":"FE Silverstein","year":"2000","unstructured":"Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The CLASS study: a randomized controlled trial. J Am Med Assoc. 2000;284:1247\u201355.","journal-title":"J Am Med Assoc"},{"key":"501_CR10","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","volume":"343","author":"C Bombardier","year":"2000","unstructured":"Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med. 2000;343:1520\u20138.","journal-title":"N Engl J Med"},{"key":"501_CR11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.amjmed.2005.09.054","volume":"119","author":"G Singh","year":"2006","unstructured":"Singh G, Fort JG, Goldstein JL, Levy RA, Hanrahan PS, Bello AE, et al. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study. Am J Med. 2006;119:255\u201366.","journal-title":"Am J Med"},{"key":"501_CR12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0140-6736(10)60673-3","volume":"376","author":"FK Chan","year":"2010","unstructured":"Chan FK, Lanas A, Scheiman J, Berger MF, Nguyen H, Goldstein JL. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial. Lancet. 2010;376:173\u20139.","journal-title":"Lancet"},{"key":"501_CR13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1542-3565(04)00619-6","volume":"3","author":"JL Goldstein","year":"2005","unstructured":"Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S, Fort JG. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol. 2005;3:133\u201341.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"501_CR14","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/j.1365-2036.2007.03312.x","volume":"25","author":"JL Goldstein","year":"2007","unstructured":"Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Aisenberg J, Bhadra P, et al. Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy. Aliment Pharmacol Ther. 2007;25:1211\u201322.","journal-title":"Aliment Pharmacol Ther"},{"key":"501_CR15","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2165\/00003495-199651030-00007","volume":"51","author":"S Noble","year":"1996","unstructured":"Noble S, Balfour JA. Meloxicam. Drugs. 1996;51:424\u201330.","journal-title":"Drugs"},{"issue":"Suppl 2","key":"501_CR16","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1007\/s000110050291","volume":"47","author":"S Kawai","year":"1998","unstructured":"Kawai S. Cyclooxygenase selectivity and the risk of gastro-intestinal complications of various non-steroidal anti-inflammatory drugs: a clinical consideration. Inflamm Res. 1998;47(Suppl 2):S102\u20136.","journal-title":"Inflamm Res"},{"key":"501_CR17","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1046\/j.1365-2036.2000.00760.x","volume":"14","author":"IA Tavares","year":"2000","unstructured":"Tavares IA. The effects of meloxicam, indomethacin or NS-398 on eicosanoid synthesis by fresh human gastric mucosa. Aliment Pharmacol Ther. 2000;14:795\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"501_CR18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0014-2999(01)01207-9","volume":"426","author":"F Giuliano","year":"2001","unstructured":"Giuliano F, Ferraz JG, Pereira R, de Nucci G, Warner TD. Cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs in humans. Ex vivo evaluation. Eur J Pharmacol. 2001;426:95\u2013103.","journal-title":"Eur J Pharmacol"},{"key":"501_CR19","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0022-3565(24)34895-5","volume":"290","author":"MR Panara","year":"1999","unstructured":"Panara MR, Renda G, Sciulli MG, Santini G, Di Giamberardino M, Rotondo MT, et al. Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects. J Pharmacol Exp Ther. 1999;290:276\u201380.","journal-title":"J Pharmacol Exp Ther"},{"key":"501_CR20","first-page":"44","volume":"45","author":"DO Stichtenoth","year":"1997","unstructured":"Stichtenoth DO, Wagner B, Fr\u00f6lich JC. Effects of meloxicam and indomethacin on cyclooxygenase pathways in healthy volunteers. J Investig Med. 1997;45:44\u20139.","journal-title":"J Investig Med"},{"key":"501_CR21","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/rheumatology\/37.9.937","volume":"37","author":"C Hawkey","year":"1998","unstructured":"Hawkey C, Kahan A, Steinbr\u00fcck K, Alegre C, Baumelou E, B\u00e9gaud B, et al. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. Br J Rheumatol. 1998;37:937\u201354.","journal-title":"Br J Rheumatol"},{"key":"501_CR22","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/rheumatology\/37.9.946","volume":"37","author":"J Dequeker","year":"1998","unstructured":"Dequeker J, Hawkey C, Kahan A, Steinbr\u00fcck K, Alegre C, Baumelou E, et al. Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis. Br J Rheumatol. 1998;37:946\u201351.","journal-title":"Br J Rheumatol"},{"key":"501_CR23","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.amjmed.2004.03.012","volume":"117","author":"G Singh","year":"2004","unstructured":"Singh G, Lanes S, Triadafilopoulos G. Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam. Am J Med. 2004;117:100\u20136.","journal-title":"Am J Med"},{"key":"501_CR24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000318746","volume":"83","author":"C Sakamoto","year":"2011","unstructured":"Sakamoto C, Soen S. Efficacy and safety of the selective cyclooxygenase-2 inhibitor celecoxib in the treatment of rheumatoid arthritis and osteoarthritis in Japan. Digestion. 2011;83:108\u201323.","journal-title":"Digestion"},{"key":"501_CR25","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/jjco\/hyp089","volume":"39","author":"N Shinohara","year":"2009","unstructured":"Shinohara N, Kumagai A, Kanagawa K, Maruyama S, Abe T, Sazawa A, et al. Multicenter phase II trial of combination therapy with meloxicam, a COX-2 inhibitor, and natural interferon-\u03b1 for metastatic renal cell carcinoma. Jpn J Clin Oncol. 2009;39:720\u20136.","journal-title":"Jpn J Clin Oncol"},{"key":"501_CR26","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2362.2010.02290.x","volume":"40","author":"S Fujimori","year":"2010","unstructured":"Fujimori S, Gudis K, Takahashi Y, Seo T, Yamada Y, Ehara A, et al. Distribution of small intestinal mucosal injuries as a result of NSAID administration. Eur J Clin Invest. 2010;40:504\u201310.","journal-title":"Eur J Clin Invest"},{"key":"501_CR27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00535-007-2155-4","volume":"43","author":"Y Niwa","year":"2008","unstructured":"Niwa Y, Nakamura M, Ohmiya N, Maeda O, Ando T, Itoh A, et al. Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study. J Gastroenterol. 2008;43:270\u20136.","journal-title":"J Gastroenterol"},{"key":"501_CR28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF01535722","volume":"33","author":"J Svedlund","year":"1988","unstructured":"Svedlund J, Sj\u00f6din I, Dotevall G. GSRS\u2014a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988;33:129\u201334.","journal-title":"Dig Dis Sci"},{"key":"501_CR29","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1211\/0022357011778070","volume":"53","author":"M Kato","year":"2001","unstructured":"Kato M, Nishida S, Kitasato H, Sakata N, Kawai S. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes. J Pharm Pharmacol. 2001;53:1679\u201385.","journal-title":"J Pharm Pharmacol"},{"key":"501_CR30","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1073\/pnas.96.13.7563","volume":"96","author":"TD Warner","year":"1999","unstructured":"Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA. 1999;96:7563\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"501_CR31","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/art.27412","volume":"62","author":"EL Mass\u00f3 Gonz\u00e1lez","year":"2010","unstructured":"Mass\u00f3 Gonz\u00e1lez EL, Patrignani P, Tacconelli S, Garc\u00eda Rodr\u00edguez LA. Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding. Arthritis Rheum. 2010;62:1592\u2013601.","journal-title":"Arthritis Rheum"},{"key":"501_CR32","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/gut.2005.080754","volume":"55","author":"A Lanas","year":"2006","unstructured":"Lanas A, Garc\u00eda-Rodr\u00edguez LA, Arroyo MT, Gomoll\u00f3n F, Feu F, Gonz\u00e1lez-P\u00e9rez A, et al. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut. 2006;55:1731\u20138.","journal-title":"Gut"},{"key":"501_CR33","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.gie.2008.08.017","volume":"69","author":"S Fujimori","year":"2009","unstructured":"Fujimori S, Seo T, Gudis K, Ehara A, Kobayashi T, Mitsui K, et al. Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy. Gastrointest Endosc. 2009;69:1339\u201346.","journal-title":"Gastrointest Endosc"},{"key":"501_CR34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0016-5085(97)70225-7","volume":"112","author":"BK Reuter","year":"1997","unstructured":"Reuter BK, Davies NM, Wallace JL. Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation. Gastroenterology. 1997;112:109\u201317.","journal-title":"Gastroenterology"},{"key":"501_CR35","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/gut.35.8.1058","volume":"35","author":"T Matsumoto","year":"1994","unstructured":"Matsumoto T, Iida M, Kuroki F, Hizawa K, Koga H, Fujishima M. Effects of diet on experimentally induced intestinal ulcers in rats: morphology and tissue leukotrienes. Gut. 1994;35:1058\u201363.","journal-title":"Gut"},{"key":"501_CR36","doi-asserted-by":"crossref","first-page":"G576","DOI":"10.1152\/ajpcell.1999.276.3.C576","volume":"276","author":"H Koga","year":"1999","unstructured":"Koga H, Aoyagi K, Matsumoto T, Iida M, Fujishima M. Experimental enteropathy in athymic and euthymic rats: synergistic role of lipopolysaccharide and indomethacin. Am J Physiol. 1999;276:G576\u201382.","journal-title":"Am J Physiol"},{"key":"501_CR37","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/gut.41.6.763","volume":"41","author":"A Anthony","year":"1997","unstructured":"Anthony A, Pounder RE, Dhillon AP, Wakefield AJ. Vascular anatomy defines sites of indomethacin induced jejunal ulceration along the mesenteric margin. Gut. 1997;41:763\u201370.","journal-title":"Gut"},{"key":"501_CR38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.giec.2003.10.009","volume":"14","author":"R Chutkan","year":"2004","unstructured":"Chutkan R, Toubia N. Effect of nonsteroidal anti-inflammatory drugs on the gastrointestinal tract: diagnosis by wireless capsule endoscopy. Gastrointest Endosc Clin N Am. 2004;14:67\u201385.","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"501_CR39","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.3748\/wjg.v11.i31.4861","volume":"11","author":"Y Hayashi","year":"2005","unstructured":"Hayashi Y, Yamamoto H, Kita H, Sunada K, Sato H, Yano T, et al. Non-steroidal anti-inflammatory drug-induced small bowel injuries identified by double-balloon endoscopy. World J Gastroenterol. 2005;11:4861\u20134.","journal-title":"World J Gastroenterol"},{"key":"501_CR40","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.cgh.2007.04.031","volume":"5","author":"L Maiden","year":"2007","unstructured":"Maiden L, Thjodleifsson B, Seigal A, Bjarnason II, Scott D, Birgisson S, et al. Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a crosssectional capsule enteroscopy study. Clin Gastroenterol Hepatol. 2007;5:1040\u20135.","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-011-0501-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-011-0501-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-011-0501-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T20:07:54Z","timestamp":1742069274000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-011-0501-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,15]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["501"],"URL":"https:\/\/doi.org\/10.1007\/s00535-011-0501-z","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,15]]}}}